Insights from ReCODE, Biomarkers, and Lifestyle Medicine
Cognitive decline is not a single disease. It is a multifactorial process influenced by metabolism, vascular health, inflammation, sleep, nutrient status, and psychological stress.
Research initiatives such as those led by Dale Bredesen and the ReCODE framework have contributed to a broader understanding of how these factors interact. While outcomes vary and claims must remain measured, the scientific contribution is clear: cognitive risk is modifiable.
Key insights include:
- insulin resistance impairs brain glucose utilization
- inflammatory burden accelerates synaptic dysfunction
- lipid imbalance influences cerebral perfusion
- sleep disruption compromises glymphatic clearance
- lifestyle patterns directly affect gene expression related to neuroplasticity
Lifestyle medicine—when applied rigorously—does not replace medical care. It complements it by addressing upstream drivers.
The Privé-Swiss perspective emphasizes legitimacy without overstatement. No protocol guarantees reversal. But evidence increasingly supports that early, targeted, systems-based intervention can slow, stabilize, or improve cognitive trajectories in select individuals.
The future of brain health lies not in single breakthroughs, but in integrated prevention grounded in biology.
